[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-333759-105":59,"doc-detail-333759-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","strategies-challenges-and-prospects-of-nanoparticles-in-gynecological-malignancies-review","Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies - Review","","Gynecologic cancers affect women worldwide and demand early detection and effective treatment to improve survival. Conventional therapies often fail or cause harsh toxicity, especially in advanced disease, driving interest in new biomedical options. Nanotechnology provides nanoparticle-enabled diagnostics and therapies, including bionanotechnology biosensors and continuous monitoring systems. The review evaluates nanocarrier platforms such as dendrimers, liposomes, nanocapsules, and nanomicelles, highlighting enhanced targeted delivery using ligand-functionalized formulations versus nonfunctionalized ones.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/strategies-challenges-and-prospects-of-nanoparticles-in-gynecological-malignancies-review/333759/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/strategies-challenges-and-prospects-of-nanoparticles-in-gynecological-malignancies-review/333759.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are early detection and treatment important for gynecologic cancers?","Question",{"text":113,"@type":114},"Early detection and prompt treatment help prevent spread of cancer cells and improve 5-year survival. Advanced-stage diagnosis is often linked to inadequate screening and unclear symptoms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What limitations do conventional therapies face in gynecologic malignancies?",{"text":118,"@type":114},"Traditional approaches such as surgery, chemotherapy, radiation, immunotherapy, and adjuvant therapy can improve outcomes, but recurrence, poor monitoring, limited effectiveness, toxicity, and drug resistance remain challenges.",{"name":120,"@type":111,"acceptedAnswer":121},"Which nanoparticle-based systems does the review highlight for diagnosis and therapy?",{"text":122,"@type":114},"The review discusses nanocarriers including dendrimers, liposomes, nanocapsules, and nanomicelles, and emphasizes targeted delivery using ligand-functionalized nanoformulations, along with imaging and continuous monitoring methods.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},333759,1790129666,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","This article is licensed under CC-BY-NC-ND 4.0   \n[http://pubs.acs.org/journal/acsodf](http://pubs.acs.org/journal/acsodf)  Review   \nStrategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies  \nYingfeng Zhang and Jing Tian*  \n Cite This: ACS Omega 2024, 9, 37459−37504  \nRead Online  \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |\n\nABSTRACT: Gynecologic cancers are a significant health issue for women globally. Early detection and successful treatment of these tumors are crucial for the survival of female patients. Conventional therapies are often ineffective and harsh, particularly in advanced stages, necessitating the exploration of new therapy options. Nanotechnology offers a novel approach to biomedicine. A novel biosensor utilizing bionanotechnology can be employed for early tumor identification and therapy due to the distinctive physical and chemical characteristics of nanoparticles. Nanoparticles have been rapidly applied in the field of gynecologic malignancies, leading to significant advancements in recent years. This study highlights the significance of nanoparticles in treating gynecological cancers. It focuses on using nanoparticles for precise diagnosis and continuous monitoring of the disease, innovative imaging, and analytic methods, as well as multifunctional drug delivery systems and targeted therapies. This review examines several nanocarrier systems, such as dendrimers, liposomes, nanocapsules, and nanomicelles, for gynecological malignancies. The review also examines the enhanced therapeutic potential and targeted delivery of ligand-functionalized nanoformulations for gynecological cancers compared to nonfunctionalized anoformulations. In conclusion, the text also discusses the constraints and future exploration prospects of nanoparticles in chemotherapeutics. Nanotechnology will offer precise methods for diagnosing and treating gynecological cancers.  \n1. INTRODUCTION  \nWomen’s health worldwide is significantly impacted by gynecologic malignancies. They are a collection of malignant tumors that impact the reproductive tissues and organs in women, such as the ovaries, uterus, cervix, vagina, vulva, and endometrium (Figure 1B).1 Cervical cancer, ovarian cancer, and endometrial cancer can contribute to more than 10% of all female cancer-related deaths.2 Early detection and prompt treatment of gynecologic cancers in women can prevent the spread of cancer cells and greatly improve the 5-year survival rate of female patients.3 Regrettably, numerous women diagnosed with gynecologic cancers are in advanced stages asa result of inadequate screening methods and vague symptoms.4 In the field of cancer therapy, utilizing traditional methods like surgery, chemotherapy, hormonal therapy, radiation therapy, immunotherapy, and adjuvant therapy can enhance the prognosis and quality of survival.5 However, challenges such as cancer recurrence, inadequate treatment monitoring, limited therapeutic effectiveness, severe toxicity, and resistance to multiple drugs persist.6 Hence, the advancement of sophisticated diagnostic and therapeutic technology remains a distant objective within the area.  \nIn recent decades, there has been a notable advancement in the creation, manipulation, and analysis of nanoparticles for cancer treatment and diagnostics. Nanomedicine involves utilizing nanoparticles and macromolecules that are typically  \nbetween 10 and 200 nm in size to create distinctive and intricate interactions with biological systems.8 Nanocarrier examples comprise self-assembled polymers, liposomes, micelles, dendrimers, hydrogels, magnetic nanoparticles, quantum dots, carbon-based nanoparticles such as carbon nanotubes and buckyballs, and oxide- or metal-based nanoparticles such as silica, colloidal gold, and titanium dioxide. Nanotechnology aims to improve the techniques used for treatment, diagnosis, or a combination of both (theranostics) in vari","cbCaif0dnK78sumB","https://ap.wps.com/l/cbCaif0dnK78sumB","pdf",4495964,46,"English","# ABSTRACT\n## INTRODUCTION\n## Nanomedicine, nanoparticles, and nanocarriers\n## Biosensors and diagnostic approaches\n## Therapeutic potential and future prospects","[{\"question\":\"Why are early detection and treatment important for gynecologic cancers?\",\"answer\":\"Early detection and prompt treatment help prevent spread of cancer cells and improve 5-year survival. Advanced-stage diagnosis is often linked to inadequate screening and unclear symptoms.\"},{\"question\":\"What limitations do conventional therapies face in gynecologic malignancies?\",\"answer\":\"Traditional approaches such as surgery, chemotherapy, radiation, immunotherapy, and adjuvant therapy can improve outcomes, but recurrence, poor monitoring, limited effectiveness, toxicity, and drug resistance remain challenges.\"},{\"question\":\"Which nanoparticle-based systems does the review highlight for diagnosis and therapy?\",\"answer\":\"The review discusses nanocarriers including dendrimers, liposomes, nanocapsules, and nanomicelles, and emphasizes targeted delivery using ligand-functionalized nanoformulations, along with imaging and continuous monitoring methods.\"}]","Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies - Review | PDF",1790003919,116]